Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EVOLOCUMAB Cause Musculoskeletal disorder? 263 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Musculoskeletal disorder have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.

263
Reports of Musculoskeletal disorder with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
6
Deaths
25
Hospitalizations

How Dangerous Is Musculoskeletal disorder From EVOLOCUMAB?

Of the 263 reports, 6 (2.3%) resulted in death, 25 (9.5%) required hospitalization, and 10 (3.8%) were considered life-threatening.

Is Musculoskeletal disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 263 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606) Back pain (5,254) Myalgia (5,061) Drug dose omission (4,914) Injection site bruising (4,409)

What Other Drugs Cause Musculoskeletal disorder?

ADALIMUMAB (2,264) ETANERCEPT (2,240) METHOTREXATE (1,039) INTERFERON BETA-1A (731) DIMETHYL (709) LEFLUNOMIDE (682) HYDROXYCHLOROQUINE (672) NATALIZUMAB (619) RITUXIMAB (603) ABATACEPT (545)

Which EVOLOCUMAB Alternatives Have Lower Musculoskeletal disorder Risk?

EVOLOCUMAB vs EXELON EVOLOCUMAB vs EXEMESTANE EVOLOCUMAB vs EXENATIDE EVOLOCUMAB vs EXFORGE EVOLOCUMAB vs EXJADE

Related Pages

EVOLOCUMAB Full Profile All Musculoskeletal disorder Reports All Drugs Causing Musculoskeletal disorder EVOLOCUMAB Demographics